Tumour-Associated Endothelial Cell Heterogeneity: From Biological Mechanisms to Precision Vascular Targeting
Expert Reviews in Molecular Medicine · 2026 · 28
DOI: 10.1017/erm.2026.10078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 09.11.2026. Verfasst von Keke Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan430030, Chi…. Hauptthemen laut MEDLINE: Endothelial Cells, Neoplasms, Neovascularization, Pathologic. Die Arbeit nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Background
Tumour-associated endothelial cells (TECs) are heterogeneous and plastic regulators of the tumour microenvironment. Their angiogenic, metabolic, barrier, and immunoregulatory programs influence tumour perfusion, metastatic dissemination, immune-cell access, and therapeutic response. However, the causal roles and clinical utility of many newly identified endothelial states remain uncertain.
Methods
This review examines the origins and functional heterogeneity of TECs, drawing on findings from single-cell and spatial studies. It discusses the implications of endothelial states for anti-angiogenic therapy, vascular normalization, immune modulation, drug delivery, combination treatment, and therapeutic resistance.
Results
Current evidence reveals endothelial states with distinct functional and therapeutic properties, although most remain descriptively characterized and lack causal or clinical validation. We propose a translational framework integrating single-cell and spatial profiling with protein-level validation, functional perturbation, vascular imaging, and longitudinal biomarkers to distinguish endothelial states that warrant suppression, normalization, reprogramming, or selective targeting.
Conclusions
TEC heterogeneity provides a rationale for precision vascular targeting. Establishing the causal functions and therapeutic relevance of endothelial states will be essential to advance vascular therapy beyond empirical angiogenesis inhibition and guide more selective treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan430030, China.
- Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumor Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wu…
- Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan430030, China.
- Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan430030, China.
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
ORCID-Profile: Hui Cheng, Liang Zhuang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Natural Science Foundation of Guangdong Province
- Tongji Hospital
- Tongji Medical College, Huazhong University of Science and Technology
Zitieren
APA
Zhao, K., Wang, Z., Xie, Y., Zhang, Y., Liu, S., Xu, Y., Cheng, H., Huang, X., Zhang, T., & Zhuang, L. (2026). Tumour-Associated Endothelial Cell Heterogeneity: From Biological Mechanisms to Precision Vascular Targeting. Expert Reviews in Molecular Medicine, 28. https://doi.org/10.1017/erm.2026.10078
Vancouver
Zhao K, Wang Z, Xie Y, Zhang Y, Liu S, Xu Y, et al. Tumour-Associated Endothelial Cell Heterogeneity: From Biological Mechanisms to Precision Vascular Targeting. Expert Reviews in Molecular Medicine. 2026;28. doi:10.1017/erm.2026.10078
BibTeX
@article{Zhao2026,
author = {Zhao, Keke and Wang, Ze and Xie, Yang and Zhang, Yijia and Liu, Shiyi and Xu, Yu and Cheng, Hui and Huang, Xiaoyuan and Zhang, Tao and Zhuang, Liang},
title = {Tumour-Associated Endothelial Cell Heterogeneity: From Biological Mechanisms to Precision Vascular Targeting},
journal = {Expert Reviews in Molecular Medicine},
year = {2026},
volume = {28},
doi = {10.1017/erm.2026.10078}
}
EUVIMED